logo
Longevity Experts Say That Mastering This One Skill Could Add Years to Your Life

Longevity Experts Say That Mastering This One Skill Could Add Years to Your Life

Yahoo25-06-2025
A new study found that among four cognitive abilities tested in older adults, verbal fluency (the ability to use language quickly and effectively) was significantly associated with a longer life span.
Experts believe verbal fluency may serve as a proxy for biological resilience, as it relies on multiple brain functions—including memory, attention, processing speed, and executive functioning—all working in sync.
Improving verbal fluency is possible at any age with regular challenges like naming games, deep conversations, strategic board games, storytelling, and even learning a new language—all of which stimulate brain function and support healthy aging.When it comes to aging, research has shown that intelligence can predict your longevity. But intelligence is a vague concept, and it doesn't give us much of an idea of what we can do to exercise our brains. However, a new study published in the journal Psychological Science has pinpointed a more specific trait in people who live longer: verbal fluency.
The researchers gave participants—aged 70 to 105—tests measuring four cognitive abilities: verbal fluency (mastery of language), perceptual speed (the ability to access patterns quickly), verbal knowledge (vocabulary), and episodic memory (ability to recall and remember personal experiences). They also developed a model that assessed their risk of death. After analyzing the data, researchers determined that out of the four cognitive abilities they tested, verbal fluency alone appeared to have a significant link to longevity—but they're not sure why.
Although the link between verbal fluency and longevity is not yet understood, Paolo Ghisletta, PhD, lead author of the study, has two possible theories. The first is that the physical body is inextricably linked to mental, emotional, and cognitive processes. 'All of these domains are just declining together, whether it's cognition, personality, emotions, or biological, medical decline in general,' he said in a statement. In addition to that, Ghisletta recognizes that verbal fluency could be a good measure of well-being, because it's a complex process involving multiple cognitive abilities, potentially including long-term memory, vocabulary, efficiency, and visual memory.
Dr. Kimberly Idoko, neurologist and medical director at Everwell Neuro, agrees, noting that verbal fluency utilizes multiple brain functions, like memory, attention, processing speed, and the ability to organize and express ideas quickly. It also depends on strong connections between different parts of the brain—especially the frontal and temporal lobes. 'When someone can find and use words with ease, it suggests that the brain's regions are connecting well,' Idoko says. 'And when fluency starts to decline, it often suggests broader issues in brain function. So, strong verbal fluency may reflect biological resilience.'
Let's break it down a bit more. 'In order to express a word, you come up with an idea or a thought,' says Polina Shkadron, neurodivergent therapist and founder of Play to Learn Consulting. 'Then, to communicate that thought to someone else, you pull from your language resources to choose specific words in a particular order so that the listener is able to also comprehend what you are describing.' Essentially, you are using language to implant your idea into someone else's mind. 'As the speaker, you also have a feedback loop, meaning that once you express your idea, you are analyzing it simultaneously to make sure that the words are exactly what you wanted in that moment and in that context,' she explains.
While having extensive knowledge of vocabulary is part of communicative interactions, it's not the only part. 'You also need to have knowledge of how language is formed and used,' Shkadron says. 'Language use, referred to as pragmatics, is the way in which we facilitate conversational interactions. We use specific terms depending on the situation and the people in that environment.'
Verbal fluency is also determined by executive functioning capacities—especially verbal working memory—as well as impulse inhibition and cognitive flexibility, Shkadron notes. 'For instance, to have an extensive conversation with someone else, your brain needs the skills to hold onto specific information, process what the other person is telling you—without interrupting them—determine whether that information is relevant or irrelevant, and keep the conversation going based on the topic being discussed,' she explains.
Related: Clear Brain Fog Instantly With These 12 Effective Strategies
The good news is that you can start improving your verbal fluency today, and keep it up over the years. 'The most important ingredients are challenge, variety, and frequency,' Idoko says. To get you started, here are some suggestions from Idoko and Shkadron.
Set a timer for one minute or 90 seconds, and pick a category—like animals, foods you'd find in a grocery store, or items you'd find outdoors in nature, things that start with the letter 'S'—and name as many as you can before the timer goes off. You can challenge yourself or others and make a game out of it. The person who named the highest number of things in the category wins. (It's also a perfect game for a road trip.) According to Idoko, this activity 'activate[s] the same circuits I test in clinical exams.'
Both Idoko and Shkadron mentioned that staying verbally active through having conversations with others is a great way to stay social and keep up with your language skills. More specifically, Shkadron recommends conversations that are about individual interests. 'People who stay verbally active through conversation, reading, or teaching tend to live longer and maintain better cognitive function,' Idoko says. 'So verbal fluency may reflect how much someone is using their brain to stay connected.'
According to Shkadron, strategic board games that require you to use all aspects of executive functioning are beneficial. She suggests Blokus, Ticket to Ride, Settlers of Catan, Rummikub, The Oregon Trail, and Bananagrams. 'The cognitive shifting and strategy that occurs involves language planning and deliberating your moves, as well as the moves of your opponents,' she explains.
Related: Do Brain Games Really Work to Boost Cognitive Fitness?
This ancient oral tradition is also a great way to flex your language skills, Idoko says. '[Storytelling] artistically uses language to develop all of the critical components involved in the communication process,' say the authors of a 2001 study on literacy techniques and storytelling. 'Storytelling develops listening skills, enhances verbal expression, increases comprehension, creates mental images, and highlights verbal reasoning.' Consider trying your hand at creative writing or journaling to get started—you don't have to be an expert to reap the benefits of storytelling.
Do you regret not taking Spanish in high school? Have you always wanted to learn Japanese? Well, there's no time like the present, regardless of your age. A 2012 study found that learning a new language is associated with the growth of the hippocampus—an area of that brain that's involved with handling memories, learning, and dealing with emotion. This is important because the hippocampus is among the first parts of the brain affected by memory loss.
Read the original article on Real Simple
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

If You'd Invested $1,000 in Viking Therapeutics 3 Years Ago, Here's How Much You'd Have Today
If You'd Invested $1,000 in Viking Therapeutics 3 Years Ago, Here's How Much You'd Have Today

Yahoo

time5 minutes ago

  • Yahoo

If You'd Invested $1,000 in Viking Therapeutics 3 Years Ago, Here's How Much You'd Have Today

Key Points Weight loss drugs are big news, and Viking has one in development in both injectable and oral form. Investors are eagerly awaiting trial results later this year. 10 stocks we like better than Viking Therapeutics › Viking Therapeutics (NASDAQ: VKTX) investors have seen a handsome return over the past three years, and this demonstrates that the real battle over biopharmaceutical stocks is won in the lab and clinical trials. Viking Therapeutics doesn't have a commercial product on the market yet and has never generated a dollar in revenue. Yet, it's made many investors wealthy. One thousand dollars invested three years ago is now worth an incredible $10,640 as of Aug. 11. Viking Therapeutics: The best may be yet to come The excitement around the stock centers on its lead development compound, VK2735. It's a GLP-1/GIP dual agonist for the treatment of obesity. Vikings VK2735 is following in the footsteps of Eli Lilly's GLP-1/GIP dual agonist tirzepatide (branded as Zepbound), and investors are hoping VK2735 can achieve similar levels of success. Where is this promising drug now VK2735 is in phase 3 trials in subcutaneous (injection) form, with results probably not due until 2027, and, arguably more excitingly, it's in phase 2 trials in an oral form. The latter has obvious benefits of convenience and comfort for patients, and management expects to report on the phase 2 trial this year. Investors have high hopes, as the phase 2 subcutaneous trial resulted in up to 88% of patients experiencing more than 10% weight loss. The phase 1 trials in oral form were also impressive (remember that phase 1 trials are fundamentally exploratory and often aim to understand safety and tolerability), with a mean weight loss of 8.2% after 28 days of dosing. These results are enough to encourage Viking investors that VK2735 could prove to be a hugely successful compound, and the results of the latest tests of the oral form are eagerly anticipated, not least by potential larger pharmaceutical companies that may try to buy the company and take VK2735 (oral) through phase 3. Should you invest $1,000 in Viking Therapeutics right now? Before you buy stock in Viking Therapeutics, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and Viking Therapeutics wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $653,427!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $1,119,863!* Now, it's worth noting Stock Advisor's total average return is 1,060% — a market-crushing outperformance compared to 182% for the S&P 500. Don't miss out on the latest top 10 list, available when you join Stock Advisor. See the 10 stocks » *Stock Advisor returns as of August 11, 2025 Lee Samaha has no position in any of the stocks mentioned. The Motley Fool recommends Viking Therapeutics. The Motley Fool has a disclosure policy. If You'd Invested $1,000 in Viking Therapeutics 3 Years Ago, Here's How Much You'd Have Today was originally published by The Motley Fool

Bausch Health (BHC) Rebounds 15.8% on Bargain-Hunting
Bausch Health (BHC) Rebounds 15.8% on Bargain-Hunting

Yahoo

time5 minutes ago

  • Yahoo

Bausch Health (BHC) Rebounds 15.8% on Bargain-Hunting

We recently published . Bausch Health Companies Inc. (NYSE:BHC) is one of the best-performing stocks on Monday. Bausch Health bounced back by 15.83 percent on Monday to close at $6.66 apiece as investors appeared to have hunted for bargains, having traded below the $6 level for seven days in a row. Monday's share price marked Bausch Health Companies Inc. (NYSE:BHC) first official claw back to the green territory since the start of the month after hovering for most of the trading days below the $5.89 closing price on July 31. It picked up to $5.94 on August 5, but only by a slight 0.85-percent gain from July 31's closing price. Year-to-date, the company's shares were down by 17.4 percent. In recent news, Bausch Health Companies Inc. (NYSE:BHC) expanded its attributable net income by 1,380 percent in the second quarter of the year to $148 million from only $10 million in the same period last year. Revenues also grew by 5 percent to $2.53 billion from $2.4 billion. Copyright: nimon / 123RF Stock Photo For the full-year period, Bausch Health Companies Inc. (NYSE:BHC) raised its revenue guidance to $10 billion to $10.25 billion, as compared with the $9.95 billion to $10.2 billion previously. While we acknowledge the potential of BHC as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the . Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Alan Tudyk Says He Was Cut From I, ROBOT Marketing After Testing Better Than Will Smith in Test Screenings — GeekTyrant
Alan Tudyk Says He Was Cut From I, ROBOT Marketing After Testing Better Than Will Smith in Test Screenings — GeekTyrant

Geek Tyrant

time6 minutes ago

  • Geek Tyrant

Alan Tudyk Says He Was Cut From I, ROBOT Marketing After Testing Better Than Will Smith in Test Screenings — GeekTyrant

Alan Tudyk just revealed a wild behind the scenes story from his time on the 2004 sci-fi blockbuster I, Robot , and it explains why so many people still don't know he was in it. Appearing on the Toon'd In with Jim Cummings podcast, Tudyk said he was dropped from the film's marketing campaign after test screenings showed he was scoring higher with audiences than the movie's leading man, Will Smith. Tudyk brought the robot Sonny to life through motion capture and voice work, but after the studio saw the test results, he claims they decided to make his involvement… vanish. 'A lot of people did not know I did Sonny the Robot in I, Robot , and there is a reason. They were doing test audiences for the movie, and they score the characters in this kind of test screening. 'I got word back: 'Alan, you are testing higher than Will Smith.' And then I was gone. I was done. There was no publicity, and my name was not mentioned.' The actor admitted the move blindsided him. 'I was so shocked. I was like, 'Wait, nobody is going to know I'm in it!' I put a lot into [that performance]. I had to move like a robot. At the time, I was very upset.' He totally has a right to be upset over that! What a crappy thing for the studio to do to an actor! I, Robot was directed by Alex Proyasand is set in 2035, it follows Smith's Chicago detective investigating the suspicious death of a robotics company founder. While society's highly intelligent robots are meant to serve humanity, Smith's character suspects one of them, Sonny, of murder. The cast also featured Bridget Moynahan, Bruce Greenwood, James Cromwell, and Chi McBride. Back in 2004, motion capture was still a relatively fresh tool in Hollywood. Aside from characters like Jar Jar Binks in Star Wars and Gollum in The Lord of the Rings , audiences hadn't seen much of it. Tudyk's work as Sonny helped push that technology forward, and he later became a fan favorite as the sarcastic droid K-2SO in Rogue One: A Star Wars Story and its Disney+ prequel series Andor . It's been over 20 years since I, Robot hit theaters, but for many fans, this might be the first time they're realizing Sonny's soul came from Alan Tudyk. Turns out, the reason they didn't know… was by design. I mean, you can't have Tudyk being better than Will Smith! Sheesh. That movie would've been so much better without Smith.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store